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Introduction
Gastrointestinal (GI) symptoms are common, and in
Sweden and other Western countries (1–3) have an
estimated prevalence of 50% for dyspepsia, irritable
bowel syndrome (IBS) and gastroesophageal reﬂux
disease (GERD) together. Many sufferers report more
than one of the disorders concomitantly (4). The dis-
orders, although often intermittent, are costly for the
society (5,6) and lingering for many of the sufferers
(3,7,8). However, the absence of GI complaints
appear stable over time (3,8): a symptom survey con-
ducted in Sweden over 7 years determined that from
subjects who were symptom free at the beginning
only 3% developed functional gastrointestinal disor-
ders (FGID) and 3% reﬂux disease after 1 year, and
this increased to 5% in each group after 7 years (8).
Community surveys state that less than half of GERD
or dyspepsia sufferers ever consult (1,3), whereas,
those with IBS appear to initiate consultation more
frequently (3). Together, FGID account for one of 20
visits in primary care (1,9,10).
Functional dyspepsia is deﬁned as dyspepsia with-
out peptic ulcer disease (PUD) or other more rare
diseases (11). In a Swedish population-based upper
endoscopy study, the prevalence of dyspepsia was
38% and symptomatic PUD was 4% (12). Thus, a
majority of those reporting dyspepsia in the popula-
tion can be expected to have functional dyspepsia.
Similarly, the symptoms of IBS in most cases repre-
sent a FGID (13). Moreover, dyspepsia and IBS often
overlap in individuals (4); thus, dyspepsia and IBS
probably have common aspects in their pathophysi-
ology (14,15) and also in healthcare seeking behav-
iour (16). By contrast, GERD, in the majority of
cases, has an acid-induced aetiology (13). Accord-
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SUMMARY
Objectives: Comparison of comorbidity and healthcare consumption in primary
healthcare subjects with persistent functional gastrointestinal disorder (FGID) and a
strictly gastrointestinal (GI) symptom-free group (SSF). Methods: A stratiﬁed sam-
ple (n ¼ 1428, 21–86 years) of subjects living in the O ¨sthammar community, Swe-
den, was limited to half of the community and classiﬁed through the Abdominal
Symptom Questionnaire (ASQ) into two study groups, one with persistent FGID
(n ¼ 71), another SSF (n ¼ 48). Symptoms were re-evaluated by means of the
ASQ at a surgery visit, as was healthcare consumption during 2 years, and the lev-
els of anxiety and depression, as measured with the Hospital Anxiety and Depres-
sion Scale. Diagnoses were set according to The International Classiﬁcation of
Diseases (ICD)-9 and the 14 diagnostic groups. Results: Of the FGID patients,
97% had a non-GI diagnosis, compared with 100% of SSF (ns). The mean number
of doctors’ consultations (OR ¼ 3.5), phone calls to doctors (OR ¼ 3.4), number
of prescriptions (OR ¼ 2.4) and number of set diagnoses (OR ¼ 3.9), anxiety level
(OR ¼ 11.5) and depression (OR ¼ 5.2) were all statistically signiﬁcantly higher
(p < 0.05) for FGID than for SSF, while the number of referrals and sick leave
were not. Besides a GI diagnosis, there was no signiﬁcant difference (p > 0.05) in
the spectrum of morbidity in terms of ICD-9 subgroup classiﬁcation, except an
increased proportion of older SSF subjects with circulatory disorders and hyperten-
sion. Conclusions: Functional gastrointestinal disorders are related to an
increased demand on primary healthcare because of an increased overall comorbid-
ity, which signiﬁes a need for a holistic healthcare approach.
What’s known
Previous studies have shown an association
between FGID and other ‘medically unexplained
physical symptoms’ such as migraine, ﬁbromyalgia,
pelvic pain etc. There is also an increased
healthcare seeking reported for people with FGID.
What’s new
This article is, to the authors’ knowledge, that the
ﬁrst report which compares primary healthcare
consumption in persons with persistent FGID with
strictly GI symptom-free controls. The ﬁndings
indicate the importance of looking for other
physical morbidity in patients who present
themselves with FGID.
doi: 10.1111/j.1742-1241.2007.01549.x
ORIGINAL PAPER
ª 2007 The Authors
234 Journal compilation ª 2007 Blackwell Publishing Ltd Int J Clin Pract, February 2008, 62, 2, 234–240ingly, it appears reasonable to investigate the burden
imposed on society by functional dyspepsia and IBS
together, excluding those with only GERD.
Psychological and other non-GI somatic illnesses
occur in FGID sufferers more frequently; conversely,
GI disorders are associated with other diseases such
as ﬁbromyalgia, headache, gynaecological disorders
(17) and psychological illness (18). As many FGID
sufferers seldom or never consult about their GI
symptoms, but rather for other complaints (19),
their entire medical record data must be examined
to understand all aspects of their comorbidity.
The aim of this study was to compare the com-
orbidity of subjects with persistent FGID with those
of a strictly GI symptom-free group (SSF), and to
compare their healthcare consumption, as registered
in their primary care medical records. The FGID
and SSF study groups were identiﬁed with the
Abdominal Symptom Questionnaire (ASQ) from a
random sample of O ¨sthammar population in 1995
and the study groups were further evaluated with
new questionnaires at a visit to their local health
centre.
Materials and methods
Setting and sampling
O ¨sthammar community (n ¼ 22,452 in 1995) is
served by ﬁve primary healthcare centres, three to
the west (Gimo, O ¨sterbybruk and Alunda) and two
to the east (O ¨regrund and O ¨sthammar city, n ¼
9959 in 1995); the latter two serve almost half of the
population. The two eastern health centres were the
only centres included in this study, as they were in a
more remote area serving the inhabitants with 24 h
primary care, including emergency care. Moreover,
the medical records were computerised, making data
collection more reliable. The eastern part did not dif-
fer from the western population in terms of age
(mean age: east 49 years, west 48 years and p ¼
0.86) or gender (males: east 39%, west 39% and
p ¼ 1). However, the mean education level was
higher (east 3.1, west 2.7 and p ¼ 0.01), although
the median ¼ 3 was the same.
From a questionnaire survey of a random sample
(n ¼ 1428, 21–86 years, mean age 49.2 years, 47%
males) of O ¨sthammar community in 1995, and
repeated in 1996, a total of 141 FGID and 97 SSF
were identiﬁed for further study: 71 FGID and 48
SSF lived in the eastern part of the community.
Details of the sampling procedure and study logistics
have been reported previously (18). Those with FGID
(mean age 45 years, range: 21–85 years) were youn-
ger than the SSF (mean age 54 years, range: 24–
82 years and p < 0.001), but the gender distribution
was equal (males: 39% FGID, 40% SSF and p ¼
0.99).
Symptom group deﬁnitions
The symptom proﬁle of each person was classiﬁed
through self-reported troublesome symptoms during
the previous 3 months entered in the postal ASQ
(20). Dyspepsia was deﬁned as ‡ 1 of 11 listed pain
and discomfort modalities (burning sensation, ach-
ing, pain, tenderness, sinking feeling, ‘butterﬂies’,
cramp, twinge, stitch, colic or gripes) at or above the
navel level, and concomitantly reporting ‡ 1 of the
symptoms: acid reﬂux, heartburn, retrosternal pain,
eructations, nausea, vomiting, early satiety, uncom-
fortable feeling of fullness after meals or abdominal
distension. Subjects reporting only gastroesophageal
reﬂux symptoms (heartburn and/or retrosternal pain)
but no concomitant abdominal pain or discomfort
were classiﬁed as having GERD and not dyspepsia:
those with such symptoms and concomitant abdomi-
nal pain or discomfort were classiﬁed into the dys-
pepsia group.
Irritable bowel syndrome was deﬁned as having
‡ 1 of the 11 pain and discomfort modalities listed
above and in any abdominal location. In addition,
‡ 1 of the symptoms, diarrhoea, constipation or
alternating diarrhoea and constipation, and ‡ 1o f
the symptoms abdominal distension, abdominal dis-
comfort or pain on defaecation, abdominal discom-
fort or pain relieved by defaecation, feeling of
incomplete defaecation or mucous stools. This deﬁ-
nition is in concordance with published guidelines at
the time of the survey (21).
Functional gastrointestinal disorder
Functional gastrointestinal disorders was deﬁned as
having dyspepsia, IBS or both. The occurrence of IBS
and dyspepsia within the FGID group (n ¼ 71) was:
in 1995; IBS n ¼ 2; dyspepsia n ¼ 43; IBS and dys-
pepsia n ¼ 26 and in 1996; IBS n ¼ 8; dyspepsia
n ¼ 25; IBS and dyspepsia n ¼ 38.
Strictly symptom free
Strictly symptom free was deﬁned as having no
reported symptom in the ASQ in the 1995 survey,
and having stated that they had had no previous
troubling abdominal symptoms. Those subjects who
had participated in two former surveys in 1988 and
1989 should also have reported no symptoms in both
of those two investigations.
Data collection
Treatment diagnoses and the number of contacts
were extracted from medical records between 1st Jan-
uary 1996 and 31st December 1997.
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The ICD-9 code was categorised into 14 disease diag-
nostic groups. As ICD-9 coding was not compulsory,
a code could be absent in the medical records and
was interpreted from the text. If a person had a diag-
nosis code from the same diagnostic group on
repeated consultations, the diagnostic group was only
registered once.
Counting contacts
Doctor phone calls, face-to-face consultations, con-
sultation diagnoses, prescriptions, referrals, sick list-
ing periods and sick listing days were obtained from
the medical records.
Anxiety and depression
Anxiety and depression were measured by a validated
questionnaire: Hospital Anxiety and Depression Scale
(HADS) (22) with possible ranges of 0–21 for each
subscale. There is no single, generally accepted refer-
ence score for HADS; the cut-off is dependent on
the sensitivity and speciﬁcity adopted (23). In this
study, the lower cut-off 7/8 for anxiety and 6/7 for
depression were chosen.
Statistical power and analysis
To have 90% power at the p < 0.05 level to detect
a 100% absolute difference in mean consultation
rate, 72 subjects in the FGID and 36 subjects in the
SSF groups were needed. This assumed an annual
consultation rate of two for the FGID and one for
the SSF group, a SD ¼ 3 in both groups and twice
as many subjects in the FGID group than in the
SSF group. Pearson’s chi-squared test, Student’s
t-test, Fisher’s exact test and the Mann–Whitney
U-test (for data with a skewed distribution) were
used for the statistical analyses. Logistic regression
was analysed with age, sex, education, depression
and anxiety as independent variables and healthcare
factors (doctor consultations, phone calls, prescrip-
tions, referrals, sick leave episodes and number of
different diagnosis) as dependent variables: all vari-
ables dichotomised. Ninety-ﬁve per cent conﬁdence
intervals (CI) were computed with parametric
methods: a p-value of 0.05 or less was considered
statistically signiﬁcant and all reported p-values were
two sided. The statistical package Stata 8 was used
for analyses (24).
Ethics
This study was part of the GiCon study approved by
the Ethics Committee of the Medical Faculty,
Uppsala University, on 5th June 1996.
Results
Doctor face-to-face and phone consultations
For any disorder there were 300 consultations for the
FGID entered in the medical records and 110 consul-
tations for the SSF groups. The healthcare actions
are summarised in Table 1.
Those with FGID consulted a doctor more often,
made more phone calls, received more diagnoses and
obtained more prescriptions than the SSF group. The
distribution of consultations and phone calls is pre-
sented in Table 2, and prescriptions and diagnoses in
Table 3.
Comorbidity
The FGID patients had a non-GI diagnosis code
recorded in a majority, 97%, of the consultations,
compared with a non-GI diagnosis code in all con-
sultations among SSF patients. Two SSF patients
within the SSF had an additional GI diagnosis set:
one with gastroesophageal reﬂux and one with mete-
orism. Comorbidity was presented as the number of
different ICD-9 diagnostic groups in each consulta-
tion, for 410 consultations (FGID: n ¼ 300; SSF:
n ¼ 110). There was no statistical signiﬁcance in the
distribution of set diagnoses for the 14 diagnostic
groups determined by univariate comparison
between the FGID and SSF groups, except for the
GI, circulatory and hypertension diagnostic groups.
In the latter two diagnostic groups, FGID patients
had a lower mean age than SSF [circulation, 58 years
(FGID) and 66 years (SSF), p ¼ 0.049: hypertension,
63 years (FGID) and 75 years (SSF), p ¼ 0.004]. The
morbidity is illustrated in Figure 1.
Referrals
There were 34 referrals recorded for the FGID and
SSF groups, and none were referred more than twice.
In the FGID group, 27% were referred to a specialist,
compared with 21% in the SSF group (ns).
Sick leave
There were no differences in either the number of sick
leave episodes or the number of sick leave days for
those with FGID and SSF, as highlighted in Table 2.
The reason for sick leave for GI disorders was 9% for
the FGID (of 956 days) and 0% for SSF (of 329 days)
and thus the corresponding ﬁgures for non-GI disor-
ders were 91% for the FGID and 100% for SSF.
Anxiety and depression
Functional gastrointestinal disorders had increased
levels of anxiety (p < 0.0001) and depression (p ¼
0.0001) and a signiﬁcant age- and sex-adjusted
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0.025) and for depression OR ¼ 5.2 (CI: 1.1–25;
0.038) (see Table 1).
Comparison with ROME II deﬁnition
The deﬁnition of dyspepsia was more restricted in
terms of combinations of symptoms than the ROME
II deﬁnition, but wider in terms of abdominal loca-
tion, as not only epigastric but also midabdominal
and ﬂank symptoms were included. The IBS deﬁni-
tion requires, aside from compulsory ‘abdominal
pain and discomfort’ a combination of bowel habit
disturbances (diarrhoea and/or constipation) and a
symptom mainly labelled as ‘supportive’ in the
ROME II deﬁnition of IBS).
Adopting the ROME II deﬁnitions for FGID (dys-
pepsia and IBS) as closely as possible, 4.8% of the
911 subjects in the population sample (18) were
erroneously classiﬁed as having FGID instead of
‘minor symptoms’, with an overall agreement of
95.2% between the combinations of FGID deﬁni-
tions.
Discussion
This study demonstrated that persistent FGID in
the general population was related to increased
comorbidity and increased healthcare consumption
because of non-GI disorders. Subjects with FGID
had more diagnoses, consultations and phone calls
to their doctors and additional medication pre-
scribed in primary and outpatient care than strictly
GI symptom-free subjects did. The increased bur-
den to healthcare was thus not explained by GI
problems, but by the whole spectrum of diagnoses
within the ICD-9 diagnostic groups also including
the hypertensive and circulatory diseases as the dif-
ference found probably is a result of the older age
of the SSF group. As it is not likely that FGID
can be a cause of all different diseases, it seems
that FGID in some way is related to somatic and
psychological distress. Personality may also play an
important part.
One strength of this study was the population-
based approach, thus, avoiding sample bias because
of healthcare-seeking behaviour in subjects with GI
complaints (25). The sampling method with repeated
reporting of dyspepsia or IBS twice for the FGID
group (1995 and 1996), and up to four times for the
SSF group (1988, 1989, 1995 and 1996), with the
same type of questionnaire (ASQ), assured deﬁned
study groups and a precise measure of the outcome
variables. The electronic medical records and the val-
idated HADS questionnaire secured valid measure-
ments of the exposure variables.
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the eastern part, there were no major differences
between the area investigated and the remainder of
O ¨sthammar. As the population in the entire O ¨stham-
mar region had a slightly lower educational level
than the Swedish population (26), the sample from
the eastern area was probably more representative of
the general Swedish population. People in the eastern
area made most outpatient and almost all non-spe-
cialist consultations within their own community
area (data on ﬁle). Thus, the consultations made
outside the catchment area could not bias the results.
The ASQ has been thoroughly validated and found
reliable (4,27).The deﬁnitions of dyspepsia and IBS
used in this study were those used in the original
study from 1988 (28) when the ﬁrst ROME criteria
(13) were unavailable. The original study deﬁnitions
were retained despite changes in later deﬁnitions, as
it allowed comparison of the prevalence of diseases
over time. The deﬁnitions used for FGID (dyspepsia
and IBS) is in good concordance with the now used
The Rome Foundation Criteria for the Functional GI
Disorders (ROME) II classiﬁcation as only 4.8% were
erroneously classiﬁed as having FGID, with an overall
agreement of 95.2% between the combinations of
Table 2 Number of consultations and phone calls for subjects with functional gastrointestinal disorder (FGID) and
strictly symptom free (SSF) 1996–1997
Number of
doctor
consultations
and phone calls
FGID
consultation
(n ¼ 300) %
SSF
consultation
(n ¼ 110) %
FGID
calls
(n ¼ 81) %
SSF
calls
(n ¼ 22) %
11–20 8 11 1 2 – – – –
7–10 5 7.0 4 8 – – – –
3–6 24 34 10 21 15 21 4 8
1–2 23 32 15 31 20 28 7 15
01 1 1 6 1 8 3 8 3 6 5 1 3 6 7 5
Total 71 100 48 100 71 100 48* 100
*One missing.
Table 3 Number of different diagnoses and number of prescriptions recorded at consultations for patients in
O ¨regrund-O ¨sthammar 1996–1997
Number of
diagnoses
per subject
FGID
(n ¼ 176) %
SSF
(n ¼ 71) %
Number of
prescriptions
per subject
FGID
(n ¼ 385) %
SSF
(n ¼ 167) %
6–8 6 8 1 2 13–33 12 17 5 10
3–5 22 31 10 21 5–12 16 22 6 13
1–2 31 44 19 40 1–4 26 37 16 33
0 12 17 18 37 0 17 24 21 44
Total 71 100 48 100 Total 71 100 48 100
FGID, functional gastrointestinal disorder; SSF, strictly symptom free.
Figure 1 Morbidity expressed as the proportion of subjects
(crude rate) with functional gastrointestinal disorder
(FGID) and strictly symptom free (SSF) that had consulted
for any ICD-9 diagnosis during 1996–1997. Univariate
signiﬁcance *p < 0.05, Fisher’s exact test
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cation was considered insigniﬁcant for the conclu-
sions.
This study was not a case–control study, but
rather a study of all subjects with FGID compared
with those repeatedly SSF within the population
sample. Subjects with FGID were on average younger
than SSF (18), as the prevalence of dyspepsia and
IBS is higher in younger age groups (8): age was
adjusted in the multivariate analysis and the mean
age analysis. A power calculation was performed
before the study but the study was not powered to
detect differences in comorbidity which means a pos-
sibility that a type II error has led to a failure to ﬁnd
the statistically signiﬁcant difference between some of
the variables.
Healthcare-seeking behaviour is complex and its
interaction with sick leave has been mainly studied
in patient samples. Patients with non-ulcer dyspepsia
are found to take excessive sick leave compared with
ulcer patients (19), but only 23% of absenteeism was
caused by GI complaints, compared with 9% in this
study. Moreover, IBS patients with high comorbidity
visit their GP more frequently than those with less
comorbidity (29). Although the issue has been high-
lighted (17), it is mainly for IBS and is not popula-
tion based.
We conclude that FGID is related to an increased
demand on primary healthcare because of an
increased overall comorbidity. Our ﬁndings indicate
that FGID is a type of intestinal reaction, related to
somatic and psychological distress in a subgroup of
subjects. To the authors’ knowledge there is no prior
study comparing persistently symptomatic FGID with
long-lasting symptom-free subjects. The results could
be generalised to the complete Swedish population,
as the study groups sampled were from a well-
deﬁned and thoroughly investigated population.
To re-assure the patient and avoid unnecessary
and expensive investigations, the treatment of people
with FGID should be through a holistic healthcare
approach. Specialist care focusing solely on GI prob-
lems may miss the target.
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